Bottom Line: Future market access in IHS depends on implementation of a sovereign account model that recognizes Tribal nations as high-agility delivery networks prioritizing clinical autonomy, cultural integration, and long-term medical self-sufficiency. For medical device and pharmaceutical manufacturers, the Indian Health Service (IHS) has historically been approached as a traditional federal payer similar to the Veterans Health Administration (VHA) or Defense Health Agency (DHA). They have...

Bottom Line By pivoting its 2025–2030 Strategic Plan toward a high-velocity functional mandate, the DHA is prioritizing mission-availability. Manufacturers must take this moment to evaluate current messaging and recalibrate their own messaging to show a direct reduction in warfighter downtime. The Defense Health Agency (DHA) is currently navigating a fundamental structural evolution between its established 2025–2030 Strategic Plan and a new set of performance-driven mandates orienting from...

Bottom Line: The PACT Act significantly scaled the VHA’s care mission. Manufacturers succeed by aligning their clinical data with the system's operational goal of providing efficient, high-volume Veteran care. The PACT Act of 2022 represents the largest expansion in VA beneficiaries in a generation, fundamentally altering the VHA’s scope of responsibilities and its operational priorities. With millions of new Veterans now eligible for care, the health system is managing a significant increase...